We conclude that GLUT8 mediates hepatic fructose uptake and HFrD-induced macrosteatosis in vivo and that substrate delivery mechanisms at the hepatocyte cell surface are a mechanism by which to modulate NAFLD pathogenesis. Here, SLC2A12 is linked to metabolic dysfunction-associated steatotic liver disease.